首页> 外文期刊>Journal of comparative effectiveness research >Hospitalization risk factors in antipsychotic-treated schizophrenia, bipolar I disorder or major depressive disorder
【24h】

Hospitalization risk factors in antipsychotic-treated schizophrenia, bipolar I disorder or major depressive disorder

机译:抗精神病药治疗精神分裂症,双相障碍或主要抑郁症的住院风险因素

获取原文
获取原文并翻译 | 示例
           

摘要

Aim: To examine hospitalization risk factors in antipsychotic-treated patients with schizophrenia, bipolar I disorder (BD-I) or major depressive disorder (MDD). Patients & methods: Using Truven Health MarketScan((R)) Commercial, Medicaid and Medicare Supplemental data (01/01/2012-06/30/2016), logistic regression models were performed to identify risk factors for both psychiatric and all-cause hospitalization in three separate analyses. Results: Significant risk factors included prior hospitalization (schizophrenia: odds ratio [95% CI]: 2.83 [2.50-3.21; psychiatric]; 2.58 [2.31-2.87; all-cause]; BD-I: 2.42 [2.23-2.63]; 2.09 [1.96-2.23]; MDD: 2.81 [2.49-3.16]; 2.21 [2.03-2.40]), previous antipsychotic treatment (schizophrenia: 1.71 [1.52-1.93]; 1.31 [1.18-1.46]; BD-I: 1.33 [1.23-1.44]; 1.22 [1.14-1.30]; MDD: 1.31 (1.11-1.54); 1.17 (1.04-1.32) and substance abuse (schizophrenia: 1.42 [1.27-1.60]; 1.37 [1.23-1.53]; BD-I: 1.72 [1.58-1.86]; 1.61 [1.50-1.72]; MDD: 1.90 [1.68-2.15] and 1.55 [1.41-1.71]). Conclusion: Prior hospitalization, previous antipsychotic treatment and substance abuse were associated with increased hospitalization risk in schizophrenia, BD-I or MDD.
机译:目的:检查抗精神病药治疗的精神分裂症患者的住院风险因素,双极I障碍(BD-I)或主要抑郁症(MDD)。患者及方法:使用Truven Health Marketscan((r))商业,医疗补助和医疗保险补充数据(01/01 / 2012-06 / 30/30/2016),进行了物流回归模型,以识别精神病和全因素的危险因素在三个单独的分析中住院治疗。结果:显着的风险因素包括先前住院治疗(精神分裂症:差距[95%CI]:2.83 [2.50-3.21;精神病]; 2.58 [2.31-2.87;全归; BD-I:2.42 [2.23-2.63]; 2.09 [1.96-2.23]; MDD:2.81 [2.49-3.16]; 2.21 [2.03-2.40]),以前的抗精神病药治疗(精神分症:1.71 [1.52-1.93]; 1.31 [1.18-1.46]; BD-I:1.33 [ 1.23-1.44]; 1.22 [1.14-1.30]; MDD:1.31(1.11-1.54); 1.17(1.04-1.32)和物质滥用(精神分裂症:1.42 [1.27-1.60]; 1.37 [1.23-1.53​​]; BD-I :1.72 [1.58-1.86]; 1.61 [1.50-1.72]; MDD:1.90 [1.68-2.15]和1.55 [1.41-1.71])。结论:先前住院治疗,先前的抗精神病药治疗和药物滥用与增加的住院风险有关精神分裂症,BD-I或MDD。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号